David Platt
2009
In 2009, David Platt earned a total compensation of $190.5K as Chief Executive Officer at Galectin Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Option Awards | $41,605 |
|---|---|
| Salary | $14,000 |
| Other | $134,917 |
| Total | $190,522 |
Platt received $134.9K in other compensation, accounting for 71% of the total pay in 2009.
Platt also received $41.6K in option awards and $14K in salary.
Rankings
In 2009, David Platt's compensation ranked 9,322nd out of 9,885 executives tracked by ExecPay. In other words, Platt earned more than 5.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,322 out of 9,885 | 6th |
Division Manufacturing | 3,505 out of 3,690 | 5th |
Major group Chemicals And Allied Products | 816 out of 866 | 6th |
Industry group Drugs | 600 out of 638 | 6th |
Industry Pharmaceutical Preparations | 421 out of 446 | 6th |
Source: SEC filing on April 11, 2011.
Platt's colleagues
We found five more compensation records of executives who worked with David Platt at Galectin Therapeutics in 2009.
2009
Theodore Zucconi
Galectin Therapeutics
Chief Executive Officer
2009
Eliezer Zomer
Galectin Therapeutics
Executive Vice President of Manufacturing and Product Development
2009
Anatole Klyosov
Galectin Therapeutics
Chief Scientist
2009
Anthony Squeglia
Galectin Therapeutics
Chief Financial Officer
2009
Maureen Foley
Galectin Therapeutics